Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
farletuzumab
.
Show all posts
Showing posts with label
farletuzumab
.
Show all posts
Tuesday, January 15, 2013
Results from Morphotek’s farletuzumab Phase III combination study on ovarian cancer
›
In continuation of my update on carboplatin and a taxane Morphotek ® Inc., a wholly-owned subsidiary of Eisai Inc., announced top...
›
Home
View web version
